| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 16.870 | 32.172 | 34.096 | 46.526 | 49.828 | 50.309 | 56.417 | 68.689 | 84.696 |
| Total Income - EUR | - | 16.870 | 32.173 | 34.097 | 46.527 | 51.896 | 50.309 | 56.417 | 68.690 | 84.697 |
| Total Expenses - EUR | - | 11.229 | 18.324 | 19.466 | 31.254 | 28.601 | 28.881 | 36.453 | 31.377 | 74.596 |
| Gross Profit/Loss - EUR | - | 5.641 | 13.849 | 14.631 | 15.273 | 23.295 | 21.428 | 19.964 | 37.313 | 10.101 |
| Net Profit/Loss - EUR | - | 5.464 | 13.527 | 14.290 | 14.808 | 22.796 | 20.935 | 19.400 | 36.640 | 7.611 |
| Employees | - | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Badimedsan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 3.424 | 2.326 | 1.263 | 253 | 0 | 0 |
| Current Assets | - | 6.171 | 16.072 | 17.486 | 13.794 | 24.407 | 21.498 | 20.098 | 37.297 | 12.149 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 2.248 | 0 | 0 | 0 | 0 | 31 | 26.825 | 6.828 |
| Cash | - | 6.171 | 13.824 | 17.486 | 13.794 | 24.407 | 21.498 | 20.067 | 10.471 | 5.321 |
| Shareholders Funds | - | 5.508 | 13.579 | 14.342 | 14.858 | 22.846 | 20.984 | 19.448 | 36.689 | 7.659 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 662 | 2.493 | 3.144 | 2.360 | 3.892 | 1.777 | 916 | 608 | 4.490 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Badimedsan Srl